Carregant...

A tale of two pities: Autologous melanoma vaccines on the brink

This paper reviews and compares two autologous vaccine technologies for human melanoma that failed to obtain marketing approval after 10–15 y of clinical development—the HSP vaccine invented by Srivastava and developed by the company, Antigenics, and the hapten-modified cellular vaccine invented by...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: Berd, David
Format: Artigo
Idioma:Inglês
Publicat: Landes Bioscience 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3551891/
https://ncbi.nlm.nih.gov/pubmed/22854662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.20923
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!